FDA Cleared | Fast Healing Cold Sore Treatment – Clinically Proven 1072nm Infrared Device With Replaceable Battery

Say Goodbye to Long-Lasting Cold Sores

If you suffer from recurrent Herpes Simplex Labialis (cold sores), you know the frustration of waiting over a week for the unsightly blister to heal. You have tried the creams and the patches, but you still miss out on important days because of the pain and embarrassment.

Now, there is a clinically proven, drug-free alternative. This 1072nm Infrared Light Therapy Device represents a breakthrough in cold sore management.

Key Features:

CLINICALLY PROVEN 1072nm TECHNOLOGY – Uses a specific narrowband infrared wavelength (1072nm ± 12nm) that has been shown in randomized controlled trials to reduce cold sore healing time by up to 48-72 hours compared to no treatment .

FDA CLASS II MEDICAL DEVICE – Cleared as a "Light Based Treatment for Cold Sores Herpes Simplex Virus-1" (Product Code: OKJ). This is not just a beauty gadget; it is regulated medical technology .

FAST 3-MINUTE TREATMENT – Simply hold the device to the affected area for approximately 3 minutes per session. The device automatically powers down after the pre-programmed treatment time .

START AT FIRST TINGLE – Designed for maximum efficacy when used at the first sign of an outbreak (tingling, itching, or redness). The invisible infrared light penetrates the skin to accelerate re-epithelialization (the healing of the skin layer) .

EASY TO USE & BATTERY OPERATED – Portable, hand-held device powered by a standard 9V battery. No messy creams, no pills, and no prescription required .

PAIN-FREE & NON-THERMAL – The device applies Low-Level Light Therapy (LLLT) which is completely painless, non-invasive, and does not generate heat, making it safe for sensitive lip.

Replaceable Battery:
Standard replaceable battery allows for instant power swaps anywhere, making it ideal for travel and eliminating downtime while waiting for a recharge.

How It Works
This device utilizes a specific band of near-infrared light (1072nm) that has been extensively studied in clinical settings. Unlike topical agents that work on the surface, the infrared energy penetrates the dermis where the virus resides. According to peer-reviewed research and FDA definitions, applying this specific light shortens the "time to healing," defined as the period until the underlying skin becomes completely re-epithelialized (new skin growth) .

The Clinical Evidence
In a randomized, double-blind, placebo-controlled study, patients using the 1072nm light device experienced a median healing time of just 129 hours (5.4 days) compared to 177 hours (7.4 days) for the placebo group . Another study published in Clinical and Experimental Dermatology showed that the device reduced the average healing time from 9.4 days to just 6.3 days.